Fasting Hyperglycemia and Associated Free Insulin and Cortisol Changes in “Somogyi-Like” Patients

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Diabetes Care

• Publication date

  1979-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.2.6.457PMID 26922819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The characteristics of a new glucose sensor for use in an artificial pancreatic beta cell.

  2008cited by this paper
• Determination of Insulin Requirements in Brittle Diabetic Patients by the Artificial Pancreas

  1978cited by this paper
• Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer.

  1978cited by this paper
• Chronic overtreatment with insulin in children and adolescents.

  1977cited by this paper
• Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics

  1977cited by this paper
• Continuous blood glucose monitoring in insulin-treated diabetes.

  1977cited by this paper
• Diurnal glucose variability and hormonal regulation.

  1977cited by this paper
• Glucose homeostasis under continuous intravenous insulin therapy in diabetics.

  1977cited by this paper
• Blood Glucose Monitoring in Symptomatic Hypoglycemia

  1976cited by this paper
• Interaction of Endogenous Growth Hormone, Cortisol, and Catecholamines with Blood Glucose in Children with Brittle Diabetes Mellitus

  1975cited by this paper
• Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

  1974cited by this paper
• Posthypoglycemic hyperglycemia in diabetic children.

  1974cited by this paper
• An assessment of the Ames-BMI blood analyzer.

  1971cited by this paper
• Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability

  1970cited by this paper
• Comparison of competitive protein binding radioassay of cortisol to double isotope dilution and Porter Silber methods.

  1970cited by this paper
• Hormonal genesis of glucose intolerance following hypoglycemia.

  1968cited by this paper
• Diurnal variation in the levels of glucose and related substances in healthy and diabetic subjects during starvation.

  1967cited by this paper
• Lack of Influence of Insulin-induced Hypoglycemia on Alimentary Hyperglycemia

  1966cited by this paper
• A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma

  1964cited by this paper
• Exacerbation of diabetes by excess insulin action.

  1959cited by this paper
• Diabetogenic effect of hyperinsulinism.

  1959cited by this paper
• Paradoxical hyperglycemia in diabetic patients treated with insulin.

  1953cited by this paper

• PFKFB2 Is Pivotal for Metabolic Flexibility and Differential Glucose Utilization

  2025cites this paper
• PFKFB2 is Pivotal for Metabolic Flexibility and Differential Glucose Utilization

  2025cites this paper
• La patogenesi del diabete mellito: I. Glicogenesi, iperglicemia, glicosuria

  2022cites this paper
• Antiglucocorticoid potential of nutraceuticals: In silico molecular docking and in vitro assessment

  2018cites this paper
• Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches

  2015cites this paper
• Insulin pump therapy (continuous subcutaneous insulin infusion).

  2007cites this paper
• A Lesson in Early Morning Hyperglycemia

  2004cites this paper
• 279 IN SEARCH OF THE SOMOGYI EFFECT

  2003cites this paper
• [Insulin sensitivity and hepatic glucose production: nycthemeral variations].

  1997cites this paper
• Functional Insulin Treatment

  1996cites this paper
• A continuous monitoring system for blood glucose measurements in conscious animals without surgery

  1994cites this paper
• The Somogyi effect

  1993cites this paper
• The Somogyi effect. Has it ever existed and what harm has it caused?

  1993cites this paper
• The dawn phenomenon and diabetes control in treated NIDDM and IDDM patients.

  1992cites this paper
• Chronobiology, Nutrition, and Diabetes Mellitus

  1992cites this paper
• Proinsulin as a possible therapeutic agent.

  1992cites this paper
• Split-Mixed Insulin Regimen With Human Ultralente Before Supper and NPH (Isophane) Before Breakfast in Children and Adolescents With IDDM

  1991cites this paper
• Physiologische Grundlagen der Insulinsubstitution

  1990cites this paper
• Morning Insulin Requirements: Critique of Dawn and Meal Phenomena

  1989cites this paper
• The Dawn Phenomenon: Nocturnal Blood Glucose Homeostasis in Insulin‐dependent Diabetes Mellitus

  1988cites this paper
• Absence of the dawn phenomenon in normal subjects.

  1988cites this paper
• Glucose Counterregulation and Its Impact on Diabetes Mellitus

  1988cites this paper
• Comparing the Biological Activity of Humulin R and Novolin R Using an Intravenous Bioassay

  1988cites this paper
• Frequency of Early-Morning Rise in Blood Glucose in Children With Diabetes at Camp

  1988cites this paper
• Non-insulin-dependent diabetic patients (NIDDMs) do not demonstrate the dawn phenomenon at presentation.

  1988cites this paper
• Somogyi and dawn phenomena: mechanisms.

  1988cites this paper
• Nocturnal Hypoglycemia Does Not Commonly Result in Major Morning Hyperglycemia in Patients With Diabetes Mellitus

  1987cites this paper
• Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.

  1987cites this paper
• Overnight Metabolic Control With Bedtime Injection of Intermediate-Acting Insulin or Continuous Subcutaneous Insulin Infusion

  1987cites this paper
• Nocturnal Insulin and C-Peptide Rhythms in Normal Subjects

  1987cites this paper
• Measurements of Glucose Control

  1987cites this paper
• Stability of insulin mixtures in disposable plastic insulin syringes

  1987cites this paper
• Dawn Phenomenon: Its Frequency in Non-Insulin-Dependent Diabetic Patients on Conventional Therapy

  1987cites this paper
• The physiological basis of insulin treatment — clinical aspects

  1986cites this paper
• Failure to detect the "dawn phenomenon" in nondiabetic subjects with markedly different patterns of nocturnal growth hormone secretion.

  1986cites this paper
• The dawn phenomenon does not occur in normal elderly subjects.

  1986cites this paper
• Occurrence of Dawn Phenomenon Without Change in Insulin Clearance in Patients With Insulin-Dependent Diabetes Mellitus

  1986cites this paper
• Pathogenesis and Prevention of the Dawn Phenomenon in Diabetic Patients Treated with CSII

  1986cites this paper
• Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus.

  1985cites this paper
• The Dawn Phenomenon: An Increased Insulin Clearance Rate During the Prebreakfast Period in Diabetic and Non-Diabetic Subjects

  1985cites this paper
• Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus.

  1985cites this paper
• Prevalence of Morning Hyperglycaemia: Determinants of Fasting Blood Glucose Concentrations in Insulin‐treated Diabetics

  1985cites this paper
• [The significance of determining the daily blood glucose profile for the evaluation of compensation in diabetes].

  1985cites this paper
• Insulin Clearance Contributes to the Variability of Nocturnal Insulin Requirement in Insulin-dependent Diabetes Mellitus

  1985cites this paper
• Influence of Growth Hormone on Overnight Insulin Requirements in Insulin-dependent Diabetes

  1985cites this paper
• Rarity of a Marked “Dawn Phenomenon” in Diabetic Subjects Treated by Continuous Subcutaneous Insulin Infusion

  1985cites this paper
• New tactics for type 2 diabetes: regimens based on intermediate-acting insulin taken at bedtime.

  1985cites this paper
• Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.

  1985cites this paper
• [The "dawn" phenomenon].

  1985cites this paper
• The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus.

  1984cites this paper
• Demonstration of a Dawn Phenomenon in Normal Human Volunteers

  1984cites this paper
• Fasting Early Morning Rise in Peripheral Insulin: Evidence of the Dawn Phenomenon in Nondiabetes

  1984cites this paper
• The Flashlight Test Lacks Validity as a Screen for Nocturnal Hypoglycemia

  1984cites this paper
• [Nocturnal hypoglycemia in type-I diabetics, an underestimated risk?].

  1984cites this paper
• C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.

  1984cites this paper
• Dawn phenomena in diabetes.

  1984cites this paper
• Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients.

  1984cites this paper
• Modern aspects of conventional insulin therapy.

  1984cites this paper
• Relative Roles of Insulin Clearance and Insulin Sensitivity in the Prebreakfast Increase in Insulin Requirements in Insulin-dependent Diabetic Patients

  1984cites this paper
• Failure of a Midnocturnal Insulin Infusion to Suppress the Increased Insulin Need for Breakfast in Insulin-dependent Diabetic Patients

  1984cites this paper
• Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia).

  1984cites this paper
• Early-Morning Hyperglycemia in Diabetic Individuals Treated with Continuous Subcutaneous Insulin Infusion

  1983cites this paper
• Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.

  1983cites this paper
• Excessive insulin therapy: biochemical effects and clinical repercussions. Current concepts of counterregulation in type I diabetes.

  1983cites this paper
• Comparative study of immunoactivity and bioactivity of sodium insulin.

  1983cites this paper
• Prandial insulin requirements in insulin-dependent diabetics: effects of size, time of day, and sequence of meals.

  1983cites this paper
• Increased gastric inhibitory polypeptide levels in patients with symptomatic postprandial hypoglycemia.

  1983cites this paper
• Examination of the Role of the Pituitary-Adrenocortical Axis, Counterregulatory Hormones, and Insulin Clearance in Variable Nocturnal Insulin Requirements in Insulin-dependent Diabetes

  1983cites this paper
• Glucagon as a Counterregulatory Hormone

  1983cites this paper
• Overnight Metabolic Control with Pulsed Intermittent Versus Continuous Subcutaneous Insulin Infusion

  1983cites this paper
• Limitations in Usefulness of Single Dose Intermediate Acting Insulin: A Rapid Response Pattern in Some Type I Diabetics

  1983cites this paper
• Improved bioassay for insulin by continuous glucose monitoring.

  1981cites this paper
• Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control.

  1981cites this paper
• Profiles of metabolic control in diabetic children-frequency of asymptomatic nocturnal hypoglycemia.

  1981cites this paper
• The Dawn Phenomenon, an Early Morning Glucose Rise: Implications for Diabetic Intraday Blood Glucose Variation

  1981cites this paper
• In search of the Somogyi effect.

  1980cites this paper
• Failure of Cortisol Blockade to Inhibit Early Morning Increases in Basal Insulin Requirements in Fasting Insulin-dependent Diabetics

  1980cites this paper
• Counterregulatory Hormones, Rebound Hyperglycemia, and Diabetic Control

  1979cites this paper